ArticleAnnals of thoracic medicine
Impact of pulmonary infarction after thromboembolism: A multicenter study.
Article in Annals of thoracic medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the impact of parenchymal infarction (PI) on the progression of pulmonary thromboembolism (PTE).
methodsThis retrospective, multicenter study evaluated patients diagnosed as having PTE via thoracic computed tomography angiography (CTA). Patients were divided into two groups, those with PI (Group 1) and those without PI (Group 2), based on CTA parenchymal windows. Clinical, demographic, radiologic, and laboratory characteristics, prognostic scores (Pulmonary embolism severity ındex [PESI]), early mortality evaluations, and 30-day mortality outcomes were recorded and compared between the groups, adhering to the European Society of Cardiology PTE guidelines.
resultsThe study included 455 patients (mean age: 63.2 ± 16.8 years; 244 women [53.6%], 211 men [46.4%]). Group 1 consisted of 160 patients (35.2%), and Group 2 included 295 patients (64.8%). The mean age in Group 1 was 59 years, with a comorbidity rate of 70%. In Group 2, these were 65 years and 87%. Fever and C-reactive protein levels were significantly higher in Group 1 (
conclusionPI, observed in approximately one-third of PTE patients, may influence certain parameters affecting the prognosis of PTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.